Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Clinical Nuclear Medicine
|
October 5, 2023
A False-Positive Bone Oligometastatic Prostate Cancer in 18 F-Choline PET/CT : Be Aware of Chronic Vascular Pitfalls
Valentin Pretet, Aurélie Moreau, Louis Larrouquere, et al.
Clinical Pharmacology and Therapeutics
|
June 17, 2020
Externally Controlled Trials: Are We There Yet?
Louis Larrouquere, Joris Giai, Jean-Luc Cracowski, et al.
Cancer Treatment Reviews
|
December 20, 2023
Pharmacotherapy for leptomeningeal disease in breast cancer
Rupert Bartsch, Katarzyna J Jerzak, Louis Larrouquere, et al.
Bulletin Du Cancer
|
May 29, 2025
[Leptomeningeal disease in breast cancer: State of the art and future directions]
Louis Larrouquere, Emilie Clement, Marie Pierre Sunyach, et al.
Clinical Nuclear Medicine
|
June 5, 2023
Discriminating Inflammatory Radiation-Related Changes From Early Recurrence in Patients With Glioblastomas: A Preliminary Analysis of 68 Ga-PSMA-11 PET/CT Compared With 18 F-FDOPA PET/CT
Aurélie Moreau, Fouzi Khayi, Aurélien Maureille, et al.
Neuro-Oncology
|
April 7, 2020
Bevacizumab in progressive disseminated atypical choroid plexus papilloma in adults
Francesca Colò, Louis Larrouquere, Romain Rivoirard, et al.
Neuro-Oncology Advances
|
June 27, 2025
Feasibility and efficacy of MEMMAT-like regimen in heavily pretreated adult patients with recurrent malignant embryonal brain tumors: A series of 6 cases
Aurelien Maureille, Enora Vauleon, David Meyronet, et al.
Neuro-Oncology Advances
|
December 2, 2024
Intensive pediatric chemotherapy regimen (PNET HR+5) in adult high-risk medulloblastoma and pineoblastoma patients
Louis Larrouquere, Christelle Dufour, Cécile Faure-Conter, et al.
JAMA Network Open
|
April 3, 2024
Tucatinib Combination Treatment After Trastuzumab-Deruxtecan in Patients With ERBB2-Positive Metastatic Breast Cancer
Jean-Sebastien Frenel, Jean Zeghondy, Catherine Guérin-Charbonnel, et al.
Fundamental & Clinical Pharmacology
|
May 13, 2020
Genesis of an emergency public drug information website by the French Society of Pharmacology and Therapeutics during the COVID-19 pandemic
Louis Larrouquere, Manon Gabin, Emmanuelle Poingt, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Clinical Nuclear Medicine
|
October 5, 2023
A False-Positive Bone Oligometastatic Prostate Cancer in 18 F-Choline PET/CT : Be Aware of Chronic Vascular Pitfalls
Valentin Pretet, Aurélie Moreau, Louis Larrouquere, et al.
Clinical Pharmacology and Therapeutics
|
June 17, 2020
Externally Controlled Trials: Are We There Yet?
Louis Larrouquere, Joris Giai, Jean-Luc Cracowski, et al.
Cancer Treatment Reviews
|
December 20, 2023
Pharmacotherapy for leptomeningeal disease in breast cancer
Rupert Bartsch, Katarzyna J Jerzak, Louis Larrouquere, et al.
Bulletin Du Cancer
|
May 29, 2025
[Leptomeningeal disease in breast cancer: State of the art and future directions]
Louis Larrouquere, Emilie Clement, Marie Pierre Sunyach, et al.
Clinical Nuclear Medicine
|
June 5, 2023
Discriminating Inflammatory Radiation-Related Changes From Early Recurrence in Patients With Glioblastomas: A Preliminary Analysis of 68 Ga-PSMA-11 PET/CT Compared With 18 F-FDOPA PET/CT
Aurélie Moreau, Fouzi Khayi, Aurélien Maureille, et al.
Neuro-Oncology
|
April 7, 2020
Bevacizumab in progressive disseminated atypical choroid plexus papilloma in adults
Francesca Colò, Louis Larrouquere, Romain Rivoirard, et al.
Neuro-Oncology Advances
|
June 27, 2025
Feasibility and efficacy of MEMMAT-like regimen in heavily pretreated adult patients with recurrent malignant embryonal brain tumors: A series of 6 cases
Aurelien Maureille, Enora Vauleon, David Meyronet, et al.
Neuro-Oncology Advances
|
December 2, 2024
Intensive pediatric chemotherapy regimen (PNET HR+5) in adult high-risk medulloblastoma and pineoblastoma patients
Louis Larrouquere, Christelle Dufour, Cécile Faure-Conter, et al.
JAMA Network Open
|
April 3, 2024
Tucatinib Combination Treatment After Trastuzumab-Deruxtecan in Patients With ERBB2-Positive Metastatic Breast Cancer
Jean-Sebastien Frenel, Jean Zeghondy, Catherine Guérin-Charbonnel, et al.
Fundamental & Clinical Pharmacology
|
May 13, 2020
Genesis of an emergency public drug information website by the French Society of Pharmacology and Therapeutics during the COVID-19 pandemic
Louis Larrouquere, Manon Gabin, Emmanuelle Poingt, et al.
Page
of 2